Newcastle disease virus vectored avian vaccines
US9616118B2 · kind B2 · utility
2Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2014 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | May 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.